Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

ClinicalTrials.gov ID: NCT00662870

Public ClinicalTrials.gov record NCT00662870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 12:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Immunogenicity and Lot Comparability of DAPTACEL™ (Aventis Pasteur Classic Five-component Pertussis Vaccine in Combination With Tetanus and Diphtheria Toxoids Adsorbed) When Administered With Other Recommended Vaccines at 2, 4, 6, and 15 to 16 Months of Age.

Study identification

NCT ID
NCT00662870
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,941 participants

Conditions and interventions

Interventions

  • DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine) Biological
  • Pentacel: DTaP-IPV/Hib Biological

Biological

Eligibility (public fields only)

Age range
42 Days to 84 Days
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2001
Primary completion
Dec 31, 2003
Completion
Dec 31, 2003
Last update posted
Jan 30, 2012

2001 – 2004

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Not listed Fayetteville, AR 72703 Arkansas 72703
Not listed Jonesboro, AR 72401 Arkansas 7240
Not listed Little Rock, AR 72211 Arkansas 72211
Not listed Fountain Valley, CA 92708 California 92708
Not listed Englewood, CO 80112 Colorado 80112
Not listed Norwich, CT 06360 Connecticut 06360
Not listed Orlando, FL 32856 Florida 32856
Not listed Marietta, GA 30062 Georgia 30062
Not listed Chicago, IL 60614 Illinois 60614
Not listed Bardstown, KY 40004 Kentucky 40004
Not listed Bossier City, LA 71111 Louisiana 71111
Not listed Bridgeton, MO 63044 Missouri 63044
Not listed Rochester, NY 14620 New York 14620
Not listed Chapel Hill, NC 27514 North Carolina 27514
Not listed Portland, OR 97201 Oregon 97201
Not listed Norristown, PA 19401 Pennsylvania 19401
Not listed Pittsburgh, PA 15213 Pennsylvania 15213
Not listed Pittsburgh, PA 15241 Pennsylvania 15241
Not listed Kingsport, TN 37664 Tennessee 37664
Not listed Austin, TX 78758 Texas 78758
Not listed Fort Worth, TX 76107 Texas 76106
Not listed San Antonio, TX 78205 Texas 78205
Not listed Provo, UT 84604 Utah 84604
Not listed Spokane, WA 99220 Washington 99220
Not listed LaCrosse, WI 54601 Wisconsin 54601
Not listed Marshfield, WI 54449 Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00662870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2012 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00662870 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →